The Life Course Immunisation Summit stressed the urgent need for improved public education, increased funding and innovative research on adult vaccination. The conference united European vaccine experts who called for cohesive EU health policies that address...

A report on the key discussions and takeaways ​Dive into the comprehensive findings of our latest Global Health Podcast Series. This pivotal report offers a wealth of knowledge and expert opinions on critical public health topics, including COVID-19 vaccine...

Data-informed Decision-making: Driving life-course immunisation in National Immunisations Programs (NIPs) CLCI works towards a vision where everyone, regardless of age or life stage, can be vaccinated and shielded from vaccine-preventable diseases (VPDs)....

A report summarising the discussions and call to action from the CLCI European Parliament roundtable held on 27 June.

A progress report that evaluates the current state of pneumococcal vaccination coverage, recommendations, and funding across 42 European countries.

This report makes a detailed assessment of the impact that fake news is having on vaccination.

This report has identified the main barriers affecting uptake of routine immunisation and outlines recommendations for stakeholders at a local, national and EU level.

The results presented here offer subjective insights from immunisation experts on the introduction of COVID-19 vaccines. The report also looks beyond the pandemic to explore the legacy of COVID and its potential to shape the future of life-course immunisation.

Almost 80% of Europeans would consult a medical professional for information about vaccines, and 65% consider them the most trustworthy source of information.

The 16th World Congress on Public Health (WCPH) was held virtually on 12-16 October 2020. The theme of the Congress “Public health for the future of humanity: analysis, advocacy and action” is even more relevant now than ever before.

In Europe poor vaccine coverage has led to large outbreaks of infectious diseases with, mainly, adolescent and adult fatalities in countries that had previously eliminated or interrupted endemic transmission.

Vaccine hesitancy exists across the globe and is seen not just in the public sphere, but also among health care professionals – reducing uptake and ultimately costing lives.